University of Texas at Austin Dell Medical School Hematology and Medical Oncology

Topics

• Cancer Immunotherapy and Biomarkers 28
• Lung Cancer Treatments and Mutations 17
• Head and Neck Cancer Studies 10
• MRI in cancer diagnosis 8
• Prenatal Screening and Diagnostics 6
• Acute Myeloid Leukemia Research 5
• Lung Cancer Diagnosis and Treatment 5
• Electroconvulsive Therapy Studies 4
• Salivary Gland Tumors Diagnosis and Treatment 4
• Brain Metastases and Treatment 3
• Cancer Treatment and Pharmacology 3
• Cervical Cancer and HPV Research 3

Most cited

1. Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 561 citations · Laura Chow

2. Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols.

   Journal for immunotherapy of cancer · 2025 · 42 citations · Laura Chow

3. Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study.

   The Lancet. Oncology · 2021 · 128 citations · Laura Chow

4. Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma.

   Journal for immunotherapy of cancer · 2022 · 92 citations · Laura Chow

5. A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer.

   British journal of cancer · 2021 · 70 citations · Laura Chow

6. Dry powders for inhalation containing monoclonal antibodies made by thin-film freeze-drying.